Omnicell OMCL underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light ...

For anyone who wants to understand Omnicell's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$5.2m due to unusual ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...